Dermatology clinical trials recruiting in California

77 recruiting dermatology trials match in California. Showing 20.

• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsRecruiting

  Phase 1 · Pfizer · Anaheim, California

• A Study of Zasocitinib in Adults With Nonsegmental VitiligoRecruiting

  Phase 2 · Takeda · Fountain Valley, California

• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental VitiligoRecruiting

  Phase 3 · Incyte Corporation · Inglewood, California

• A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Enveda Therapeutics · Encinitas, California

• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic TreatmentRecruiting

  N/A · Sanofi · Bakersfield, California

• Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting

  N/A · University of California, San Diego · La Jolla, California

• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisRecruiting

  Phase 2 · Hoffmann-La Roche · Los Angeles, California

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Fountain Valley, California

• Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced DietRecruiting

  N/A · University of California, Davis · Sacramento, California

• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 3 · Nektar Therapeutics · Fountain Valley, California

• A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoRecruiting

  Phase 2 · Eli Lilly and Company · Fremont, California

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting

  Phase 3 · Bristol-Myers Squibb · Encinitas, California

• Molecular Signatures of Cutaneous Dupilumab ResponseRecruiting

  Phase 4 · University of California, San Francisco · San Francisco, California

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Cerritos, California

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisRecruiting

  Phase 2 · LEO Pharma · Fountain Valley, California

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Fountain Valley, California

• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 / Phase 3 · Bluefin Biomedicine, Inc. · Encino, California

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting

  Phase 3 · Takeda · Chula Vista, California

• The Effects of Audio-Based Therapy on Anxiety in PsoriasisRecruiting

  N/A · University of California, San Francisco · San Francisco, California

• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic DermatitisRecruiting

  Phase 2 · Novartis Pharmaceuticals · Fountain Valley, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.